The next round of the Academy of Medical Sciences Springboard scheme will open soon. The University can submit up to 4 application. We will be running a university Expression of Interest (EOI) process to select applicants to the scheme.
The Academy of Medical Sciences Springboard scheme offers £125,000 funding over 2 years towards research costs and professional development. The scheme is targeted at those in the early stages of their first independent research position and have not yet been in receipt of substantial research funding. Applications are encouraged from across the biomedical field from molecular, cellular and structural biology to anatomical, physiological, psychological, epidemiological and public health research areas.
Timeline
Internal Expression of Interest deadline: Friday 18th April noon. EOIs should include the completed form and an up-to-date CV (including publications, previous research funding and employment history)
Candidates Informed of Outcome: Wednesday 23rd April.
BU deadline to nominate Candidates to AMS: Friday 25th April noon
AMS Deadline for nominated applicants: Open 30th April and close 4th June.
Please contact Kate Percival (kpercival@bournemouth.ac.uk) if you would like to submit an EOI.
The Academy of Medical Sciences Springboard Round 10
UKRI Future Leaders Fellowships Round 8 – Internal Process Launched










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease